CClinicalTrials.gg
CompletedNCT07593703SPCUpdated May 18, 2026

Evaluation of the Mental, Physical and Social Conditions of Prison Entrants in the Nord-Pas-de-Calais Region" - Cross-sectional Survey Representative Sample, Prevalence Study

An observational study in Mental Health Issue, sponsored by University Hospital, Lille. Completed. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-18.

Sponsored by University Hospital, Lille · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
697
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the study was to estimate prevalence rates of psychiatric and substance use disorders in male and female prisoners on admission to prison in the north of France and compare the frequency of these disorders to the general population.

Read the detailed description

This cross-sectional survey on Mental Health in the Prison Population (MHPP), conducted between March 2014 and April 2017, interviewed 653 randomly selected men and women who had recently been committed to the French general population prison system in the Nord and Pas-de-Calais departments.

The prevalence rates were then compared with data from the Mental Health in the General Population (MHGP) survey, a general population survey in the Nord and Pas-de-Calais departments. A control sample was taken from the MHGP survey with a ratio of one case (MHPP) to three controls (MHGP) matching on age and sex.

02

Conditions studied

  • Mental Health Issue

Keywords

  • france prison
03

In context

Lead sponsor

University Hospital, Lille is the lead sponsor of 625 studies on the registry; 141 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

consecutively committed people in eight of the nine remand prisons of Nord and Pas-de-Calais in France

Eligibility criteria

Inclusion Criteria: consecutively committed people in eight of the nine remand prisons of Nord and Pas-de-Calais in France

inclusion- (a) provide informed consent to participate in the survey, (b) speak French, (c) aged 18 years or older, (d) free of any mental or psychological incapacity to participate due to acute decompensation of a psychiatric disorder or severe substance withdrawal (i.e., health condition requiring emergency hospitalization), and (e) had been incarcerated for less than 72 h (sentenced or on remand)

Exclusion Criteria:(a) no informed consent to participate in the survey, (b)do not speak French, (c) aged under18 years (d) with any mental or psychological incapacity to participate due to acute decompensation of a psychiatric disorder or severe substance withdrawal (i.e., health condition requiring emergency hospitalization), and (e) had been incarcerated for less than 72 h (sentenced or on remand)

-

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
697 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. psychiatric and substance use disorders

    diagnosis

    Time frame: March 2014 to April 2017,

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07593703
Lead sponsor
University Hospital, Lille
Responsible party
Sponsor
First posted
May 18, 2026
Start date
Mar 10, 2014
Primary completion
Mar 9, 2017
Completion
Mar 9, 2017
Last update
May 18, 2026

Study contacts

Pierre THOMAS, MD, PhD
study chair · University Hospital, Lille

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion